Feed RVTY
RV

Revvity RVTY · NYSE

$150.85 -1.17% (-$1.79)

Market cap
$17.0B
Enterprise value
$19.3B
P/E
71.7x
Forward P/E
26.2x
PEG
-
P/S
5.8x
P/FCF
30.4x
EV/EBITDA
25.2x
ROIC
2.9%
Gross margin
52.1%
Net margin
8.2%
Dividend yield
0.18%
Payout ratio
13.2%
Net debt/EBITDA
3.0x
Beta
1.06
Free float
91.9%

About the company

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. With a global network and localized agility, the company serves a diverse range of organizations from pharmaceutical and biotech to clinical labs, academia, and governments. It is headquartered in Waltham, MA.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Prahlad R. Singh

Employees

11,000

Headquarters

Waltham

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.